RESMED INC (RMD) Financials
Annual revenue, profitability and per-share results for RESMED INC, as reported in SEC filings.
Revenue · FY2026
$5.65B
▲ 9.9%YoY
Net income · FY2026
$1.52B
▲ 8.8%YoY
Gross margin · FY2026
61.1%
Diluted EPS · FY2026
$10.43
▲ 9.7%YoY
Annual income statement
| Period | Revenue | Net income | Gross profit | Dil. EPS | Free cash flow | Op. margin | Rev. growth |
|---|---|---|---|---|---|---|---|
| FY2026 | $5.65B | $1.52B | $3.45B | $10.43 | $1.65B | 33.4% | +9.8% |
| FY2025 | $5.15B | $1.40B | $3.05B | $9.51 | $1.66B | 32.8% | +9.8% |
| FY2024 | $4.69B | $1.02B | $2.66B | $6.92 | $1.30B | 28.2% | +10.9% |
| FY2023 | $4.22B | $897.56M | $2.36B | $6.09 | $573.63M | 26.8% | +18.0% |
Figures as reported in RESMED INC's 10-K filings on SEC EDGAR. Fiscal years may differ from calendar years.
Never miss a RMD filing.
Get an email when RMD files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Source: SEC EDGAR.